Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

Pennock S, Haddock LJ, Eliott D, Mukai S, Kazlauskas A. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog Retin Eye Res. 2014 May; 40:16-34.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.